Paul W. Hoelscher, EVP, CFO at Horizon Therapeutics Public Ltd Co (HZNP), sold 100,000 shares at $115.17 ($11.5M) on 2022-04-20, disclosed to the SEC on 2022-04-22.
Open-market sale of $11.5M HZNP by EVP, CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $114.36 | 28,458 | $3.3M | 28.4% |
| 2 | $114.36 | 28,458 | $3.3M | 28.4% |
| 3 | $115.17 | 21,542 | $2.5M | 21.6% |
| 4 | $115.17 | 21,542 | $2.5M | 21.6% |
| Total | $114.71 avg | 100,000 | $11.5M | 100% |
| Filing → |
| HZNP | SELL | 2021-12-30 | $943K | — | Filing → |
| HZNP | SELL | 2021-05-14 | $18.5M | — | Filing → |
| HZNP | SELL | 2020-08-25 | $4.5M | — | Filing → |